THE MANAGEMENT OF WOMEN WITH THROMBOPHILIA IN PREPARATION FOR IN VITRO FERTILIZATION
- Authors: Mirashvili M.I.1, Zaynulina M.S.1, Kogan I.Y.1, Gzgzyan A.M.1, Rzayeva R.N.1
-
Affiliations:
- FSBI “D. O. Ott Research Institute of Obstetrics and Gynecology” NWB RAMS
- Issue: Vol 61, No 5 (2012)
- Pages: 60-67
- Section: Articles
- URL: https://journals.rcsi.science/jowd/article/view/1308
- DOI: https://doi.org/10.17816/JOWD61560-67
- ID: 1308
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Marina Ivanovna Mirashvili
FSBI “D. O. Ott Research Institute of Obstetrics and Gynecology” NWB RAMS
Email: mmirashvili@mail.ru
resident
Marina Sabirovna Zaynulina
FSBI “D. O. Ott Research Institute of Obstetrics and Gynecology” NWB RAMS
Email: iagmail@ott.ru
prof., M.D., Deputy director for clinical and scientific work
Igor Yuryevich Kogan
FSBI “D. O. Ott Research Institute of Obstetrics and Gynecology” NWB RAMS
Email: ikogan@mail.ru
M.D., docent, Academic Secretary
Aleksandr Mkrtychiyevich Gzgzyan
FSBI “D. O. Ott Research Institute of Obstetrics and Gynecology” NWB RAMS
Email: agzgzyan@hotmail.com
M.D, Head of the Department of assisted reproductive technology
Roza Nuraddinovna Rzayeva
FSBI “D. O. Ott Research Institute of Obstetrics and Gynecology” NWB RAMS
Email: r.rzaeva@yandex.ru
resident
References
- Шмелева В. М. Роль гипергомоцистеинемии в формировании протромботических нарушений системы гемостаза: автореф... д-ра мед. наук. — СПб., 2010 . — 30 с.
- Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization / Sanmarco M. [et al.] // Ann. N. Y. Acad. Sci. — 2007. — Vol. 1108. — P. 457–465.
- Antinuclear antibody reduces the pregnancy rate in the first IVF-ET treatment cycle but not the cumulative pregnancy rate without specific medication / Kikuchi K. [et al.] // Am. J. Reprod. Immunol. — 2003. — Vol. 50, N 4. — 363–367.
- Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients / Denis A. L. [et al.] // Fertil. Steril. — 1997. — Vol. 67. — P. 1084–1090.
- Antiphospholipid antibodies in women having in vitro fertilization / Birdsall M. A. [et al.] // Hum. Reprod. — 1996. — Vol. 11. — P. 1185–1189.
- Aune B., Oian P., Osterud B. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in-vitro fertilization // Hum. Reprod. — 1993. — Vol. 8. — P. 1349–1352.
- Chan W. S., Dixon M. E. The «ART» of thromboembolism: a review of assisted reproductive technology and thromboembolic complications // Thromb. Res. —2008. — Vol. 121, N 6. — P. 713–726.
- Combined jugular and subclavian vein thrombosis following assisted reproductive technology: new observation / Salomon O. [et al.] // Fertil Steril 2009. — Vol. 92, N 2. — P.620–625.
- Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis / Westerlund E. [et al.] // Thromb. Res. — 2011. —Dec 7. [Epub ahead of print].
- Diagnostic evaluation of women experiencing repeated in vitro fertilization failure / Vaquero E. [et al.] // Eur. J. Obstet. Gynecol. Reprod. Biol. — 2006. — Vol. 125, N 1. — P.79–84.
- Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state? / Aune B. [et al.] // Hum. Reprod. — 1991. — Vol. 6. — P. 925–927.
- Embryo implantation after assisted reproductive procedures and maternal thrombophilia / Martinelli I. [et al.] // Haematologica. — 2003. — Vol. 88, N 7. — P. 789–793.
- Fiedler K., Würfel W. Effectivity of heparin in assisted reproduction // Eur. J. Med. Res. — 2004. — Vol. 9, N 4. — P. 207–214.
- Heby O. DNA methylation and polyamines in embryonic development and cancer // Int. J. Dev. Biol. — 1995. — Vol. 39. — P. 753–757.
- Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study / Biron C. [et al.] // Fertil. Steril. — 1997. — Vol. 67. — P. 104–109.
- In vitro fertilization. Do short-term changes in estrogen levels produce increased fibrinolysis? / Magnani B. [et al.] // Am. J. Clin. Pathol. — 1999. — Vol. 112. — P.485–491.
- In vitro fertilization-induced alterations in coagulation and fibrinolysis as measured by thromboelastography / Harnett M. J. [et al.] // Anesth. Analg. — 2002. — Vol. 95, N 4. — P.1063–1066.
- Incidence of autoimmune antibodies in failed embryo transfer cycles / Birkenfeld A. [et al.] // Am. J. Reprod. Immunol. — 1994. — Vol. 31. — P. 65–68.
- Increased rates of thrombophilia in women with repeated IVF failure / Azem F. [et al.] // Hum. Reprod. — 2004. — Vol. 19. — P. 368–370.
- Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial / Qublan H. // Hum. Fertil. — 2008. — Vol. 11, N 4. — P. 246–253.
- Lox C., Canez M., Prien S. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism // Int. J. Fertil. Womens Med. — 1998. — Vol. 43. — P. 34–39.
- Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial / Urman B. [et al.] // Hum. Reprod. — 2009. — Vol. 24, N 7. — P. 1640–1647.
- More on: the ‘ART’ behind the clot – solving the mystery / Bauersachs R. M.[et al.] // J. Thromb. Haemost. — 2007. — Vol. 5. — P. 438–439.
- Nelson S. M. Prophylaxis of VTE in women — during assisted reproductive techniques // Thromb. Res. — 2009. — Vol. 123. — P. 8–15.
- Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation / Andersson O. [et al.] // Thromb. Haemost. — 1997. — Vol. 77. — P. 901–904.
- Sharif K. W., Ghunaim S. Management of 273 cases of recurrent implantation failure: results of a combined evidence-based protocol // Reprod Biomed Online. — 2010. — Vol. 21, N 3. — P. 373–380.
- The cumulative incidence of venous thromboembolism during pregnancy and puerperium: an 11 year Danish population based study of 63 300 pregnancies / Anderson B. S. [et al.] // Acta Obstet. Gynecol. Scand. — 1998. — Vol. 77. — P. 110–113.
- The European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE) / J. de Mouzon [et al.] // Hum. Reprod. — 2010. — Vol. 25, N 8. — P. 1851–1862. — (Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE).
- The possible role of hyperhomocysteinemia on IVF outcome / Pacchiarotti A. [et al.] // J. Assist. Reprod. Genet. — 2007. — Vol. 24, N 10. — P. 459–462.
- Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis / Di Nisio M. [et al.] // Blood. — 2011. — Vol. 118, N 10. — P. 2670–2678.